Zalunfiban, a glycoprotein IIb/IIIa inhibitor specifically formulated for rapid subcutaneous administration, has been ...

A study was conducted to examine the predictive performance of an AI ECG algorithm for identifying occlusive myocardial infarction.

A major analysis led by the Centro Nacional de Investigaciones Cardiovasculares (CNIC), in collaboration with international ...

A trial finds a liberal vs restrictive transfusion threshold for at-risk cardiac patients may improve heart failure and ...

The benefit of beta-blockers after myocardial infarction in patients with a preserved left ventricular ejection fraction ...

Gender-affirming hormone therapy use is associated with increased cardiovascular risk among transgender men but not transgender women.

Background Guidelines strongly recommend reperfusion therapy, including thrombolysis and percutaneous coronary intervention, ...

There is a bidirectional association between myocardial infarction and late-onset epilepsy, according to a recent study.

Adding the PCSK9 inhibitor evolocumab to standard lipid-lowering therapy significantly reduced first major cardiovascular ...

Myocardial infarction is significantly associated with the development of epilepsy and nonstroke vascular death in older adults, new research shows.

Bristol Myers and Johnson & Johnson ended the Librexia ACS trial after an interim review showed low efficacy, while AF and ...